Lumida
/LYB
⌘K
LyondellBasell Industries NV

LyondellBasell Industries NV

LYB
$59.17USD+2.37%+1.37 today

MARKET CAP

19.1B

P/E (TTM)

31.8x

FWD P/E

5.9x

DAY RANGE

$59 – $60

52W RANGE

$42
$84

AI Summary

Stalk
Buy NowMedium

LYB is consolidating in an early Stage 1 base following a terminal downtrend, with repaired short-term EMAs and an active Bullish Pivot Point signaling failure of downside control and the onset of structural repair. The price is pulling back into rising 9/21 EMAs near dynamic support without signs of exhaustion, supporting a medium-term bullish bias and favoring a tactical buy now at the EMA confluence.

  • $2.3B cash flow in 2025; 95% cash conversion supports dividends and capex
  • North America/Europe polyethylene demand highest since Q3 2022 boosts margin potential
  • Margins are ~45% below historical norms, suppressing earnings
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

LyondellBasell Industries N.V. (NYSE: LYB) is a leading global chemical company, operating primarily in the manufacturing of polyolefins, chemicals, and refined products. The firm is active in various sectors, notably packaging, automotive, and construction, while concurrently embracing sustainability and circular economy initiatives. Positioned as a significant player in the petrochemical industry, LyondellBasell is adapting to evolving market dynamics and consumer preferences, with a focus on cost-efficient production and innovation in advanced polymer solutions.

Bull says

  • $2.3B cash flow in 2025; 95% cash conversion supports dividends and capex
  • North America/Europe polyethylene demand highest since Q3 2022 boosts margin potential
  • Achieved $800M in cash improvements; targeting $600M additional in 2026
  • Progress on MORTEC I recycling facility underpins sustainable, circular-economy growth
  • High earnings and 2.4% dividend yields plus strong oil-sensitivity enhance returns
  • Solid liquidity and manageable leverage preserve financial flexibility

Bear says

  • Margins are ~45% below historical norms, suppressing earnings
  • 2025 revenue dropped 8% YoY to $10.8B; EPS down to $1.70 from $2.10
  • Maintenance and unplanned downtime cost hundreds of millions in EBITDA
  • Negative profitability and growth factor scores signal operational inefficiencies
  • Momentum factor is negative, indicating subdued stock performance
  • Weak Chinese demand amid geopolitical and regulatory risks may delay recovery

Investment themes with LYB

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM
High Beta -0.12%

Stocks with high volatility relative to market

AMD · DELL · MPWR

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 06-30-2026neutral

Transcript signals

Bull points

  • LYB remains well positioned as a top North American producer with a leading product portfolio, a strong domestic market share, and robust customer relationships built over decades.
  • As for LYB, we expect our operating rates to improve in second quarter, as Channel Blue remains on track for a successful turnaround and is starting back up as we speak. With this, we are targeting 85% utilization across the segment during the second quarter.
  • Segment EBITDA improved significantly as cracker utilization increased to approximately 80% in the first quarter from the 55% in the fourth quarter. The increase resulted from the completion of a turnaround at our largest European cracker and improved operational flexibility.

Bear points

  • During the first quarter, ONP America's EBITDA was $251 million. The company's first quarter performance was impacted by planned and unplanned downtime.
  • We also experienced an unplanned outage at our Lake Charles JV that resulted in several weeks of downtime.
  • Higher feedstock costs resulted in additional headwinds for the integrated polyethylene margins. North American industry demand for polyolefins had a soft start in 2025, with March year-to-date polyethylene and polypropylene sales volumes down 2% and 1%, respectively.
Read full transcript analysis ›